(VIANEWS) - Catalyst Pharmaceuticals (CPRX), Arista Networks (ANET), The Ensign Group (ENSG) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Catalyst Pharmaceuticals (CPRX)
54.1% sales growth and 20.98% return on equity
Catalyst Pharmaceuticals, Inc. is a biopharmaceutical firm that focuses on the development and commercialization of therapies for individuals with neurological and rare neuromuscular diseases.
Catalyst Pharmaceuticals's sales growth this year is expected to be 42.6% and 15.4% for next year.
Year-on-year quarterly revenue growth grew by 23.5%, now sitting on 140.83M for the twelve trailing months.
Volume
Today's last reported volume for Catalyst Pharmaceuticals is 1178410 which is 5.66% below its average volume of 1249110.
Catalyst Pharmaceuticals's sales growth for the next quarter is 54.1%. The company's growth estimates for the current quarter and the next is 54.5% and 80%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 20.98%.
Volatility
Catalyst Pharmaceuticals's last day, last week, and last month's current intraday variation average was 1.66%, 3.81%, and 2.39%, respectively.
Catalyst Pharmaceuticals's highest amplitude of average volatility was 4.88% (day), 7.10% (last week), and 5.10% (last month), respectively.
Catalyst Pharmaceuticals's Stock Yearly Top and Bottom Value
Catalyst Pharmaceuticals's stock is valued at $8.55 at 16:22 EST, under its 52-week high of $8.65 and way above its 52-week low of $4.81.
Catalyst Pharmaceuticals's Moving Average
Catalyst Pharmaceuticals's worth is way higher than its 50-day moving average of $7.07 and way above its 200-day moving average of $7.01.2. Arista Networks (ANET)
15.6% sales growth and 22.58% return on equity
Arista Networks, Inc. designs, markets, sells and supports cloud networking solutions throughout the Americas, Europe, Middle East, Africa, Asia-Pacific, and Africa.
Arista Networks's sales growth this year is expected to be 23.6% and 12.6% for next year.
Year-on-year quarterly revenue growth grew by 23.7%, now sitting on 2.77B for the twelve trailing months.
Volume
Today's last reported volume for Arista Networks is 976926 which is 50.12% below its average volume of 1958590.
Arista Networks's sales growth for the next quarter is 15.6%. The company's growth estimates for the current quarter and the next is 12.8% and 9.6%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 22.58%.
Volatility
Arista Networks's last day, last week, and last month's current intraday variation average was 2.59%, 1.37%, and 1.84%, respectively.
Arista Networks's highest amplitude of average volatility was 3.06% (day), 3.78% (last week), and 3.58% (last month), respectively.
Arista Networks's Stock Yearly Top and Bottom Value
Arista Networks's stock is valued at $101.37 at 16:22 EST, way under its 52-week high of $134.14 and way above its 52-week low of $65.52.
Arista Networks's Moving Average
Arista Networks's worth is way under its 50-day moving average of $113.87 and above its 200-day moving average of $92.32.3. The Ensign Group (ENSG)
12.2% sales growth and 20.33% return on equity
The Ensign Group, Inc. offers health care services for the post-acute continuum as well as other ancillary business.
The Ensign Group's sales growth this year is anticipated to be 12.7% and 9.2% for next year.
Year-on-year quarterly revenue growth grew by 13.7%, now sitting on 2.71B for the twelve trailing months.
Volume
Today's last reported volume for The Ensign Group is 165647 which is 34.13% below its average volume of 251476.
The Ensign Group's sales growth for the next quarter is 12.2%. The company's growth estimates for the ongoing quarter and the next is 12.4% and 13.2%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 20.33%.
Volatility
The Ensign Group's last day, last week, and last month's current intraday variation average was 2.16%, 1.06%, and 1.70%, respectively.
The Ensign Group's highest amplitude of average volatility was 1.90% (day), 2.73% (last week), and 2.94% (last month), respectively.
The Ensign Group's Stock Yearly Top and Bottom Value
The Ensign Group's stock is valued at $73.47 at 16:22 EST, way below its 52-week high of $94.25 and higher than its 52-week low of $68.29.
The Ensign Group's Moving Average
The Ensign Group's worth is under its 50-day moving average of $77.15 and below its 200-day moving average of $79.28.4. Equifax (EFX)
5.9% sales growth and 21.56% return on equity
Equifax Inc. offers information solutions, human resource business process outsourcing and other services to businesses, governments and consumers.
Equifax's sales growth this year is anticipated to be 16.7% and 6.3% for next year.
Year-on-year quarterly revenue growth grew by 14.5%, now sitting on 4.79B for the twelve trailing months.
Volume
Today's last reported volume for Equifax is 318913 which is 69.13% below its average volume of 1033360.
Equifax's sales growth for the next quarter is 5.9%. The company's growth estimates for the present quarter and the next is a negative 8% and negative -11%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 21.56%.
Volatility
Equifax's last day, last week, and last month's current intraday variation average was 1.58%, 1.94%, and 1.31%, respectively.
Equifax's highest amplitude of average volatility was 1.71% (day), 3.16% (last week), and 2.54% (last month), respectively.
Equifax's Stock Yearly Top and Bottom Value
Equifax's stock is valued at $192.20 at 16:22 EST, way below its 52-week high of $296.63 and way higher than its 52-week low of $161.87.